Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China · Delayed Price · Currency is CNY 16.60
+0.24 (1.47%)
Aug 4, 2026, 3:00 PM CST
SHA:605177 Market Cap
SHA:605177 has a market cap or net worth of 1.87 billion as of August 4, 2026. Its market cap has decreased by -20.51% in one year.
Market Cap
1.87B
Enterprise Value
2.40B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
16.60
ChartMarket Cap Chart
Since November 25, 2020, SHA:605177's market cap has decreased from 5.09B to 1.87B, a decrease of -63.31%. That is a compound annual growth rate of -16.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.87B | -6.75% |
| Dec 31, 2025 | 2.00B | -9.67% |
| Dec 31, 2024 | 2.22B | -26.27% |
| Dec 29, 2023 | 3.01B | 32.27% |
| Dec 30, 2022 | 2.27B | -27.57% |
| Dec 31, 2021 | 3.14B | -22.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Model Organisms Center | 2.47B |
| Novoprotein Scientific | 2.45B |
| Shandong Sito Bio-technology | 2.32B |
| Shanghai Universal Biotech | 2.20B |
| Jilin Jian Yisheng Pharmaceutical | 2.14B |
| Suzhou Fushilai Pharmaceutical | 2.07B |
| Shanghai Hile Bio-Technology | 1.86B |
| Jiangsu CoWin Biotech | 1.85B |